Tactile Systems Technology, Inc. delivered robust financial results for the third quarter of 2025, with total revenue increasing 17% year-over-year to $85.8 million. The company saw a substantial rise in net income by 59% to $8.2 million and adjusted EBITDA by 34% to $14.4 million, reflecting effective business transformation and product innovation. Both lymphedema and airway clearance product lines contributed to this growth, and the company also repaid its term loan and authorized a new share repurchase program.
Total revenue increased by 17% year-over-year, reaching $85.8 million in Q3 2025.
Net income surged by 59% to $8.2 million, with diluted EPS at $0.36 per share.
Adjusted EBITDA grew by 34% to $14.4 million, demonstrating improved operational leverage.
The company repaid its $24.0 million term loan and authorized a new $25.0 million share repurchase program.
Tactile Systems updated its full-year 2025 financial outlook, raising expectations for both total revenue and adjusted EBITDA, reflecting increased confidence in business trajectory and execution of financial and operational initiatives.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance